Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) (2010 - 2026)
Harvard Bioscience (HBIO) reported EPS (Weighted Average and Diluted) of -$0.77 for Q1 2026, down 899.43% quarter-over-quarter from -$0.08 in Q4 2025.
Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.77 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.77, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.77 (changed N/A YoY), and the FY2025 annual result was -$1.29, down 352.66% from the prior year.
- EPS (Weighted Average and Diluted) eased to -$0.77 in Q1 2026 per HBIO's latest filing, from -$0.08 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.06 in Q2 2022 and troughed at -$0.77 in Q1 2026.
- A 5-year average of -$0.11 and a median of -$0.04 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) soared 700.0% in 2022, then sank 18625.93% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.05 in 2022, then rose by 28.27% to -$0.04 in 2023, then surged by 101.1% to $0.0 in 2024, then tumbled by 18625.93% to -$0.08 in 2025, then slumped by 899.43% to -$0.77 in 2026.
- Business Quant data shows HBIO's EPS (Weighted Average and Diluted) at -$0.77 in Q1 2026, -$0.08 in Q4 2025, and $0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.77 |
| Dec 31, 2025 | -0.08 |
| Dec 31, 2024 | 0.00 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | -0.05 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | -0.17 |
| Jun 30, 2021 | -0.01 |
| Jun 30, 2020 | -0.04 |
| Mar 31, 2020 | -0.12 |
| Dec 31, 2019 | 0.02 |
| Sep 30, 2019 | -0.07 |
| Jun 30, 2019 | -0.01 |
| Mar 31, 2019 | -0.06 |
| Dec 31, 2018 | 0.09 |
| Sep 30, 2018 | -0.01 |